MedPath
NMPA Approval

Emedastine Difumarate Sustained-release Capsules

国药准字H20194035

February 6, 2024

国药准字H20080744

Drug Information

富马酸依美斯汀缓释胶囊

璇美

胶囊剂

2mg

化学药品

February 6, 2024

Company Information

Applicant Company

眉山经济开发区新区香樟路5号

Manufacturing Company

四川省眉山经济开发区新区香樟路5号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸依美斯汀缓释胶囊 - NMPA 批准文号 | MedPath